Merck’s antiviral COVID-19 pill approved by U.S. FDA for at-home use

Posted by on December 23, 2021 9:50 am
Categories: Global Stories

Merck’s drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce hospitalizations and deaths by around 30 per cent.

Leave a Reply

Your email address will not be published.